CDSA Schedules: Difference between revisions
No edit summary |
m Text replacement - "\{\{fr\|([^\}\}]+)\}\}" to "fr:$1" |
||
Line 1: | Line 1: | ||
[[fr:Annexes_de_la_LRCDAS]] | |||
{{LevelTwo}} | {{LevelTwo}} | ||
{{HeaderCrimLaw}} | {{HeaderCrimLaw}} |
Latest revision as of 15:22, 14 July 2024
Changes to Schedules
- Amendments to Schedules
- Schedules
60 The Governor in Council may, by order, amend any of Schedules I to VIII by adding to them or deleting from them any item or portion of an item, where the Governor in Council deems the amendment to be necessary in the public interest.
– CDSA
SCHEDULE I
(Sections 2 to 7, 29, 55 and 60)
1. Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:
- (1) Opium
- (2) Codeine (methylmorphine)
- (3) Morphine (7,8–didehydro–4,5–epoxy–17–methylmorphinan–3,6–diol)
- (4) Thebaine (paramorphine) and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
- (5) Acetorphine (acetyletorphine)
- (6) Acetyldihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol acetate)
- (7) Benzylmorphine (7,8–didehydro–4,5–epoxy–17–methyl–3–(phenylmethoxy) morphinan–6–ol)
- (8) Codoxime (dihydrocodeinone O–(carboxymethyl) oxime)
- (9) Desomorphine (dihydrodeoxymorphine)
- (10) Diacetylmorphine (heroin)
- (11) Dihydrocodeine (4,5–epoxy–3–methoxy–17–methylmorphinan–6–ol)
- (12) Dihydromorphine (4,5–epoxy–17–methylmorphinan–3,6–diol)
- (13) Ethylmorphine (7,8–didehydro–4,5–epoxy–3–ethoxy–17–methylmorphinan–6–ol)
- (14) Etorphine (tetrahydro–7α–(1–hydroxy–1–methyl-butyl)–6,14–endo–ethenooripavine)
- (15) Hydrocodone (dihydrocodeinone)
- (16) Hydromorphinol (dihydro–14–hydroxymorphine)
- (17) Hydromorphone (dihydromorphinone)
- (18) Methyldesorphine (Δ6–deoxy–6–methylmorphine)
- (19) Methyldihydromorphine (dihydro–6–methylmorphine)
- (20) Metopon (dihydromethylmorphinone)
- (21) Morphine–N–oxide (morphine oxide)
- (22) Myrophine (benzylmorphine myristate)
- (23) Nalorphine (N–allylnormorphine)
- (24) Nicocodine (6–nicotinylcodeine)
- (25) Nicomorphine (dinicotinylmorphine)
- (26) Norcodeine (N–desmethylcodeine)
- (27) Normorphine (N–desmethylmorphine)
- (28) Oxycodone (dihydrohydroxycodeinone)
- (29) Oxymorphone (dihydrohydroxymorphinone)
- (30) Pholcodine (3–[2–(4–morpholinyl)ethyl]morphine)
- (31) Thebacon (acetyldihydrocodeinone)
but not including
- (32) Apomorphine (5,6,6a,7–tetrahydro–6–methyl–4H–dibenzo[de,g]quinoline–10,11–diol) and its salts
- (33) Cyprenorphine (N–(cyclopropylmethyl)–6,7,8,14–tetrahydro–7α–(1–hydroxy–1–methylethyl)–6,14–endo–ethenonororipavine) and its salts
- (34) Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts
- (34.1) Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts
- (34.2) Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts
- (34.3) Methylnaltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts
- (34.4) Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts
- (35) Narcotine (6,7–dimethoxy–3–(5,6,7,8–tetra-hydro–4–methoxy–6–methyl–1,3–dioxolos [4,5–g]isoquinolin–5–yl)–1(3H)–isobenzofuranone) and its salts
- (36) Papaverine (1–[(3,4–dimethoxyphenyl)methyl]–6,7–dimethoxyisoquinoline) and its salts
- (37) Poppy seed
2. Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:
- (1) Coca leaves
- (2) Cocaine (benzoylmethylecgonine)
- (3) Ecgonine (3–hydroxy–2–tropane carboxylic acid)
3. Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:
- (1) Allylprodine (3–allyl–1–methyl–4–phenyl–4–piperidinol propionate)
- (2) Alphameprodine (α–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
- (3) Alphaprodine (α–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
- (4) Anileridine (ethyl 1–[2–(p–aminophenyl)ethyl]–4–phenylpiperidine–4–carboxylate)
- (5) Betameprodine (ß–3–ethyl–1–methyl–4–phenyl–4–piperidinol propionate)
- (6) Betaprodine (ß–1,3–dimethyl–4–phenyl–4–piperidinol propionate)
- (7) Benzethidine (ethyl 1–(2–benzyloxyethyl)–4–phenylpiperidine–4–carboxylate)
- (8) Diphenoxylate (ethyl 1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
- (9) Difenoxin (1–(3–cyano–3,3–diphenylpropyl)–4–phenylpiperidine–4–carboxylate)
- (10) Etoxeridine (ethyl 1–[2–(2–hydroxyethoxy) ethyl]–4–phenylpiperidine–4–carboxylate)
- (11) Furethidine (ethyl 1–(2–tetrahydrofurfury loxyethyl)–4–phenylpiperidine–4–carboxylate)
- (12) Hydroxypethidine (ethyl 4–(m–hydroxyphenyl)–1–methylpiperidine–4–carboxylate)
- (13) Ketobemidone (1–[4–(m–hydroxyphenyl)–1–methyl–4–piperidyl]–1–propanone)
- (14) Methylphenylisonipecotonitrile (4–cyano–1–methyl–4–phenylpiperidine)
- (15) Morpheridine (ethyl 1–(2–morpholinoethyl)–4–phenylpiperidine–4–carboxylate)
- (16) Norpethidine (ethyl 4–phenylpiperidine–4–carboxylate)
- (17) Pethidine (ethyl 1–methyl–4–phenylpiperidine–4–carboxylate)
- (18) Phenoperidine (ethyl 1–(3–hydroxy–3–phenylpropyl)–4–phenylpiperidine–4–carboxylate)
- (19) Piminodine (ethyl 1–[3–(phenylamino)propyl]–4–phenylpiperidine–4–carboxylate)
- (20) Properidine (isopropyl 1–methyl–4–phenylpiperidine–4–carboxylate)
- (21) Trimeperidine (1,2,5–trimethyl–4–phenyl–4–piperidinol propionate)
- (22) Pethidine Intermediate C (1–methyl–4–phenylpiperidine–4–carboxylate)
but not including
- (23) Carperidine (ethyl 1–(2–carbamylethyl)–4–phenylpiperidine–4–carboxylate) and its salts
- (24) Oxpheneridine (ethyl 1–(2–hydroxy–2–phenylethyl)–4–phenylpiperidine–4–carboxylate) and its salts
4. Phenazepines, their salts, derivatives and salts of derivatives including:
- (1) Proheptazine (hexahydro–1,3–dimethyl–4–phenyl–1H–azepin–4–ol propionate)
but not including
- (2) Ethoheptazine (ethyl hexahydro–1–methyl–4–phenyl–azepine–4–carboxylate) and its salts
- (3) Metethoheptazine (ethyl hexahydro–1,3–dimethyl–4–phenylazepine–4–carboxylate) and its salts
- (4) Metheptazine (methylhexahydro-1,2-dimethyl-4-phenylazepine-4-carboxylate) and its salts
5. Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
- (1) Dimethylaminodiphenylbutanonitrile (4–cyano–2–dimethylamino–4,4–diphenylbutane)
- (2) Dipipanone (4,4–diphenyl–6–piperidino–3–heptanone)
- (3) Isomethadone (6–dimethylamino–5–methyl–4,4–diphenyl–3–hexanone)
- (4) Methadone (6–dimethylamino–4,4–diphenyl–3–heptanone)
- (5) Normethadone (6–dimethylamino–4,4–diphenyl–3–hexanone)
- (6) Norpipanone (4,4–diphenyl–6–piperidino–3–hexanone)
- (7) Phenadoxone (6–morpholino–4,4–diphenyl–3–heptanone)
6. Methadols, their salts, derivatives and salts of derivatives including:
- (1) Acetylmethadol (6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
- (2) Alphacetylmethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
- (3) Alphamethadol (α–6–dimethylamino–4,4–diphenyl–3–heptanol)
- (4) Betacetylmethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol acetate)
- (5) Betamethadol (ß–6–dimethylamino–4,4–diphenyl–3–heptanol)
- (6) Dimepheptanol (6–dimethylamino–4,4–diphenyl–3–heptanol)
- (7) Noracymethadol (α–6–methylamino–4,4–diphenyl–3–heptanol acetate)
7. Phenalkoxams, their salts, derivatives and salts of derivatives including:
- (1) Dimenoxadol (dimethylaminoethyl 1–ethoxy–1,1–diphenylacetate)
- (2) Dioxaphetyl butyrate (ethyl 2,2–diphenyl–4–morpholinobutyrate)
- (3) Dextropropoxyphene ([S–(R*,S*)]–α–[2–(dimethylamino)–1–methylethyl]–α–phenylbenzeneethanol, propanoate ester)
8. Thiambutenes, their salts, derivatives and salts of derivatives including:
- (1) Diethylthiambutene (N,N–diethyl–1–methyl–3,3–di–2–thienylallylamine)
- (2) Dimethylthiambutene (N,N,1–trimethyl–3,3–di–2–thienylallylamine)
- (3) Ethylmethylthiambutene (N–ethyl–N,1–dimethyl–3,3–di–2–thienylallylamine)
9. Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
- (1) Dextromoramide (d–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
- (2) Diphenylmorpholinoisovaleric acid (2–methyl–3–morpholino–1,1–diphenylpropionic acid)
- (3) Levomoramide (l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl)pyrrolidine)
- (4) Racemoramide (d,l–1–(3–methyl–4–morpholino–2,2–diphenylbutyryl) pyrrolidine)
10. Morphinans, their salts, derivatives and salts of derivatives including:
- (1) Buprenorphine (17–(cyclopropylmethyl)–α–(1,1–dimethylethyl)–4,5–epoxy–18,19–dihydro–3–hydroxy–6–methoxy–α–methyl–6,14–ethenomorphinan–7–methanol)
- (2) Drotebanol (6ß,14–dihydroxy–3,4–dimethoxy–17–methylmorphinan)
- (3) Levomethorphan (l–3–methoxy–17–methylmorphinan)
- (4) Levorphanol (l–3–hydroxy–17–methylmorphinan)
- (5) Levophenacylmorphan (l–3–hydroxy–17–phenacylmorphinan)
- (6) Norlevorphanol (l–3–hydroxymorphinan)
- (7) Phenomorphan (3–hydroxy–17–(2–phenylethyl)morphinan)
- (8) Racemethorphan (d,1–3–methoxy–17–methylmorphinan)
- (9) Racemorphan (d,l–3–hydroxy–N–methylmorphinan)
but not including
- (10) Dextromethorphan (d–1,2,3,9,10,10a–hexahydro–6–methoxy–11–methyl–4H–10,4a–iminoethano–phenanthren) and its salts
- (11) Dextrorphan (d–1,2,3,9,10,10a–hexahydro–11–methyl–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
- (12) Levallorphan (l–11–allyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
- (13) Levargorphan (l–11–propargyl–1,2,3,9,10,10a–hexahydro–4H–10,4a–iminoethanophenanthren–6–ol) and its salts
- (14) Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and its salts
- (15) Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and its salts
11. Benzazocines, their salts, derivatives and salts of derivatives including:
- (1) Phenazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–phenethyl–2,6–methano–3–benzazocin–8–ol)
- (2) Metazocine (1,2,3,4,5,6–hexahydro–3,6,11–trimethyl–2,6–methano–3–benzazocin–8–ol)
- (3) Pentazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(3–methyl–2–butenyl)–2,6–methano–3–benzazocin–8–ol)
but not including
- (4) Cyclazocine (1,2,3,4,5,6–hexahydro–6,11–dimethyl–3–(cyclopropylmethyl)–2,6–methano–3–benzazocin–8–ol) and its salts
12. Ampromides, their salts, derivatives and salts of derivatives including:
- (1) Diampromide (N–[2–(methylphenethylamino)propyl] propionanilide)
- (2) Phenampromide (N–(1–methyl–2–piperidino) ethyl) propionanilide)
- (3) Propiram (N–(1–methyl–2–piperidinoethyl)–N–2–pyridylpropionamide)
13. Benzimidazoles, their salts, derivatives and salts of derivatives including:
- (1) Clonitazene (2–(p–chlorobenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
- (2) Etonitazene (2–(p–ethoxybenzyl)–1–diethylaminoethyl–5–nitrobenzimidazole)
- (3) Bezitramide (1–(3–cyano–3,3–diphenylpropyl)–4–(2–oxo–3–propionyl–1–benzimidazolinyl)–piperidine)
14. Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
- (1) Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)
15. Piritramide (1–(3–cyano–3,3–diphenylpropyl)–4–(1–piperidino)piperidine–4–carboxylic acid amide), its salts, derivatives and salts of derivatives
16. Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:
- (1) Acetyl–α–methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] acetanilide)
- (2) Alfentanil (N–[1–[2–(4–ethyl–4,5–dihydro–5–oxo–1H–tetrazol–1–yl)ethyl]–4–(methoxymethyl)–4–piperidyl]propionanilide)
- (3) Carfentanil (methyl 4–[(1–oxopropyl)phenylamino]–1–(2–phenethyl)–4–piperidinecarboxylate)
- (4) p–Fluorofentanyl (4'fluoro–N–(1–phenethyl–4–piperidyl) propionanilide)
- (5) Fentanyl (N–(1–phenethyl–4–piperidyl) propionanilide)
- (6) ß–Hydroxyfentanyl (N–[1–(ß–hydroxyphenethyl)–4–piperidyl] propionanilide)
- (7) ß–Hydroxy–3–methylfentanyl (N–[1–(ß–hydroxyphenethyl)–3–methyl–4–piperidyl] propionanilide)
- (8) α–Methylfentanyl (N–[1–(α–methylphenethyl)–4–piperidyl] propionanilide)
- (9) α–Methylthiofentanyl (N–[1–[1–methyl–2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
- (10) 3–Methylfentanyl (N–(3–methyl–1–phenethyl–4–piperidyl) propionanilide)
- (11) 3–Methylthiofentanyl (N–[3–methyl–1–[2–(2–thienyl) ethyl]–4–piperidyl] propionanilide)
- (11.1) Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
- (12) Sufentanil (N–[4–(methoxymethyl)–1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
- (13) Thiofentanyl (N–[1–[2–(2–thienyl)ethyl]–4–piperidyl] propionanilide)
17. Tilidine (ethyl2–(dimethylamino)–1–phenyl–3–cyclohexene–1–carboxylate), its salts, derivatives and salts of derivatives
17.1 Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
18. Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
19. Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
- (1) amphetamine (α-methylbenzene-ethanamine)
- (2) N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
- (3) 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
- (4) 3,4-methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
- (5) 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
- (6) 4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
- (7) 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
- (8) N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
- (9) 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
- (10) 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
- (11) N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
- (12) N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
- (13) 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
- (14) 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
- (15) 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
- (16) 4-ethoxyamphetamine (4-ethoxy-α-methylbenzeneethanamine)
- (17) Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
- (18) N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
- (19) N-(2-Hydroxyethyl)-α-meth-ylbenzeneethanamine
- (20) N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
- (21) 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)
20. Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
21. 4-hydroxybutanoic acid (GHB) and any of its salts
22. Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers
23. AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers
24. MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
- (1) Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)
- (2) Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)
- (3) Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)
- (4) Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)
but not including
- (5) Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
25. W-18 (4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
26. U-47700 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide), its salts, derivatives, isomers and analogues, and salts of derivatives, isomers and analogues, including
- (1) Bromadoline (4-bromo-N-(2-(dimethylamino)cyclohexyl)benzamide)
- (2) U-47109 (3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)benzamide)
- (3) U-48520 (4-chloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide)
- (4) U-50211 (N-(2-(dimethylamino)cyclohexyl)-4-hydroxy-N-methylbenzamide)
- (5) U-77891 (3,4-dibromo-N-methyl-N-(1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide)
1996, c. 19, Sch. I; SOR/97-230, ss. 1 to 6; SOR/99-371, ss. 1, 2; SOR/99-421, s. 1(E); SOR/2005-235, s. 1; SOR/2005-271, 337; 2012, c. 1, s. 44; SOR/2012-176; SOR/2015-190; SOR/2016-107, s. 1; 2017, c. 7, s. 46; SOR/2017-13, ss. 1 to 5; SOR/2017-275; SOR/2017-277, s. 1; SOR/2018-70, ss. 1, 2, 3(F).
–
SCHEDULE II
(Sections 2, 3, 4 to 7, 10, 29, 55 and 60)
1. [Repealed, 2018, c. 16, s. 204]
2. Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts — including those that fall within the following core chemical structure classes:
- (1) Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3’-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
- (i) Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
- (ii) Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
- (iii) 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
- (iv) 5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940)
- (v) 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)
- (2) Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
- (i) 1-pentyl-3-(1-naphthoyl)indole (JWH-018)
- (ii) 1-butyl-3-(1-naphthoyl)indole (JWH-073)
- (iii) 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)
- (iv) 1-hexyl-3-(1-naphthoyl)indole (JWH-019)
- (v) 1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)
- (vi) 1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)
- (vii) 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)
- (viii) 1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200)
- (ix) 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210)
- (x) 1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
- (xi) 1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220)
- (xii) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201)
- (xiii) 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201)
- (xiv) 1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)
- (xv) ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2)
- (3) Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
- (i) 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307)
- (4) Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
- (i) 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)
- (ii) 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251)
- (iii) 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302)
- (5) Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
- (i) 1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233)
- (6) Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
- (i) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144)
- (ii) (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)
- (iii) (1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260)
- (7) Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
- (i) 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)
- (ii) 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)
- (8) Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
- (i) N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
- (ii) N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48)
- (iii) N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
- (iv) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
- (9) Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
- (i) N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)
- (ii) N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA)
1996, c. 19, Sch. II; SOR/98-157; SOR/2003-32, s. 1; SOR/2015-192; 2017, c. 7, s. 47; 2018, c. 16, s. 204.
–
SCHEDULE III
(Sections 2, 4 to 7.1, 10, 29, 55 and 60)
1 [Repealed, 2012, c. 1, s. 45]
2 Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
- (1) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
- (2) Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
- (3) Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
- (4) 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)
- (5) 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)
- (6) 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
- (7) Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
- (8) Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
3 Methaqualone (2–methyl–3–(2–methylphenyl)–4(3H)–quinazolinone) and any salt thereof [PD: also referred to as "Quaaludes"]
4 Mecloqualone (2–methyl–3–(2–chlorophenyl)–4(3H)–quinazolinone) and any salt thereof
5 Lysergic acid diethylamide (LSD) (N,N–diethyllysergamide) and any salt thereof
6 N,N–Diethyltryptamine (DET) (3–[(2–diethylamino) ethyl]indole) and any salt thereof
7 N,N–Dimethyltryptamine (DMT) (3–[(2–dimethylamino) ethyl]indole) and any salt thereof
8 N–Methyl–3–piperidyl benzilate (LBJ) (3–[(hydroxydiphenylacetyl)oxy]–1–methylpiperidine) and any salt thereof
9 Harmaline (4,9–dihydro–7–methoxy–1–methyl–3H–pyrido(3,4–b)indole) and any salt thereof
10 Harmalol (4,9–dihydro–1–methyl–3H–pyrido(3,4–b)indol–7–ol) and any salt thereof
11 Psilocin (3–[2–(dimethylamino)ethyl]–4–hydroxyindole) and any salt thereof
12 Psilocybin (3–[2–(dimethylamino)ethyl]–4–phosphoryloxyindole) and any salt thereof
13 N–(1–phenylcyclohexyl)ethylamine (PCE) and any salt thereof
14 1–[1–(2–Thienyl) cyclohexyl]piperidine (TCP) and any salt thereof
15 1–Phenyl–N–propylcyclohexanamine and any salt thereof
16 Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
17 Mescaline (3,4,5–trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
18 [Repealed, SOR/2017-249, s. 1]
19 Cathinone ((-)-α-aminopropiophenone) and its salts
20 Fenetylline (d,l–3,7–dihydro–1,3–dimethyl–7–(2–[(1–methyl–2–phenethyl)amino]ethyl)–1H–purine–2, 6–dione) and any salt thereof
21 2–Methylamino–1–phenyl–1–propanone and any salt thereof
22 1–[1–(Phenylmethyl)cyclohexyl]piperidine and any salt thereof
23 1–[1–(4–Methylphenyl)cyclohexyl]piperidine and any salt thereof
24 [Repealed, SOR/2016-73, s. 1]
25 and 26 [Repealed, 2012, c. 1, s. 46]
27 Aminorex (5-phenyl-4,5-dihydro-1,3-oxazol-2-amine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
- (1) 4-Methylaminorex (4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine)
- (2) 4,4’-Dimethylaminorex (4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine)
28 Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
29 Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
30 Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
31 Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
32 Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
33 Benzylpiperazine [BZP], namely 1-benzylpiperazine and its salts, isomers and salts of isomers
34 Trifluoromethylphenylpiperazine [TFMPP], namely 1-(3-trifluoromethylphenyl)piperazine and its salts, isomers and salts of isomers
35 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description : any substance that has a 1-amino-2-phenylethane structure substituted at the 2’ and 5’ or 2’ and 6’ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group — whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group — and its salts and derivatives and salts of derivatives, including
- (1) 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
- (2) 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
- (3) 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
- (4) 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)
1996, c. 19, Sch. III; SOR/97-230, ss. 7 to 10; SOR/98-173, s. 1; SOR/2000-220, s. 1; SOR/2003-32, ss. 2, 3, 4(F), 5; SOR/2003-412; SOR/2005-235, s. 2; 2012, c. 1, ss. 45, 46; SOR/2012-66; SOR/2016-73; SOR/2016-107, s. 2; 2017, c. 7, s. 48; SOR/2017-13, s. 6; SOR/2017-44, 249.
– {{{2}}}
SCHEDULE IV
(Sections 2, 4 to 7.1, 10, 29, 55 and 60)
1. Barbiturates, their salts and derivatives including
- (1) Allobarbital (5,5–diallylbarbituric acid)
- (2) Alphenal (5–allyl–5–phenylbarbituric acid)
- (3) Amobarbital (5–ethyl–5–(3–methylbutyl)barbituric acid)
- (4) Aprobarbital (5–allyl–5–isopropylbarbituric acid)
- (5) Barbital (5,5–diethylbarbituric acid)
- (6) [Repealed, SOR/2017-13, s. 7]
- (7) Butabarbital (5–sec–butyl–5–ethylbarbituric acid)
- (8) Butalbital (5–allyl–5–isobutylbarbituric acid)
- (9) Butallylonal (5–(2–bromoallyl)–5–sec–butylbarbituric acid)
- (10) Butethal (5–butyl–5–ethylbarbituric acid)
- (11) Cyclobarbital (5–(1–cyclohexen–1–yl)–5–ethylbarbituric acid)
- (12) Cyclopal (5–allyl–5–(2–cyclopenten–1–yl)barbituric acid)
- (13) Heptabarbital (5–(1–cyclohepten–1–yl)–5–ethylbarbituric acid)
- (14) Hexethal (5–ethyl–5–hexylbarbituric acid)
- (15) Hexobarbital (5–(1–cyclohexen–1–yl)–1,5–dimethylbarbituric acid)
- (16) Mephobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
- (17) Methabarbital (5,5–diethyl–1–methylbarbituric acid)
- (18) Methylphenobarbital (5–ethyl–1–methyl–5–phenylbarbituric acid)
- (19) Propallylonal (5–(2–bromoallyl)–5–isopropylbarbituric acid)
- (20) Pentobarbital (5–ethyl–5–(1–methylbutyl)barbituric acid)
- (21) Phenobarbital (5–ethyl–5–phenylbarbituric acid)
- (22) Probarbital (5–ethyl–5–isopropylbarbituric acid)
- (23) Phenylmethylbarbituric Acid (5–methyl–5–phenylbarbituric acid)
- (24) Secobarbital (5–allyl–5–(1–methylbutyl)barbituric acid)
- (25) Sigmodal (5–(2–bromoallyl)–5–(1–methylbutyl) barbituric acid)
- (26) Talbutal (5–allyl–5–sec–butylbarbituric acid)
- (27) Vinbarbital (5–ethyl–5–(1–methyl–1–butenyl)barbituric acid)
- (28) Vinylbital (5–(1–methylbutyl)–5–vinylbarbituric acid) but not including
- (29) Barbituric Acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
- (30) 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
2. Thiobarbiturates, their salts and derivatives including:
- (1) Thialbarbital (5–allyl–5–(2–cyclohexen–1–yl)–2–thiobarbituric acid)
- (2) Thiamylal (5–allyl–5–(1–methylbutyl)–2–thiobarbituric acid)
- (3) Thiobarbituric Acid (2–thiobarbituric acid)
- (4) Thiopental (5–ethyl–5–(1–methylbutyl)–2–thiobarbituric acid)
3. Chlorphentermine (1–(p–chlorophenyl)–2–methyl–2–aminopropane) and any salt thereof
4. Diethylpropion (2–(diethylamino)propiophenone) and any salt thereof
5. Phendimetrazine (d–3,4–dimethyl–2–phenylmorpholine) and any salt thereof
6. Phenmetrazine (3–methyl–2–phenylmorpholine) and any salt thereof
7. Pipradrol (α,α–diphenyl–2–piperidinemethanol) and its salts
8. Phentermine (α,α–dimethylbenzeneethanamine) and any salt thereof
9. Butorphanol (l–N–cyclobutylmethyl–3,14–dihydroxymorphinan) and its salts
10. Nalbuphine (N–cyclobutylmethyl–4,5–epoxy–morphinan–3,6,14–triol) and its salts
11. Glutethimide (2–ethyl–2–phenylglutarimide)
12. Clotiazepam (5–(o–chlorophenyl)–7–ethyl–1,3–dihydro–1–methyl–2H–thieno[2,3–e]–1,4–diazepin–2–one) and any salt thereof
13. Ethchlorvynol (ethyl–2–chlorovinyl ethynyl carbinol)
14. Ethinamate (1–ethynylcyclohexanol carbamate)
15. Mazindol (5–(p–chlorophenyl)–2,5–dihydro–3H–imidazo[2,1–a]isoindol–5–ol)
16. Meprobamate (2–methyl–2–propyl–1,3–propanediol dicarbamate)
17. Methyprylon (3,3–diethyl–5–methyl–2,4–piperidinedione)
18. Benzodiazepines, their salts and derivatives, including: [PD: often referred to as "benzos"]
- (1) Alprazolam (8–chloro–1–methyl–6–phenyl–4H–s–triazolo[4,3–a][1,4] benzodiazepine)
- (2) Bromazepam (7–bromo–1,3–dihydro–5–(2–pyridyl)–2H–1, 4–benzodiazepin–2–one)
- (2.1) Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
- (3) Camazepam (7–chloro–1,3–dihydro–3–(N,N–dimethylcarbamoyl)–1–methyl–5–phenyl–2H–1, 4–benzodiazepin–2–one)
- (4) Chlordiazepoxide (7–chloro–2–(methylamino)–5–phenyl–3H–1,4–benzodiazepine–4–oxide)
- (5) Clobazam (7–chloro–1–methyl–5–phenyl–1H–1,5–benzodiazepine–2,4(3H,5H)–dione)
- (6) Clonazepam (5–(o–chlorophenyl)–1,3–dihydro–7–nitro–2H–1,4–benzodiazepin–2–one)
- (7) Clorazepate (7–chloro–2,3–dihydro–2,2–dihydroxy–5–phenyl–1H–1,4–benzodiazepine–3–carboxylic acid)
- (8) Cloxazolam (10–chloro–11b–(o–chlorophenyl)–2,3, 7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin 6–(5H)–one)
- (9) Delorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
- (10) Diazepam (7–chloro–1,3–dihydro–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (11) Estazolam (8–chloro–6–phenyl–4H–s–triazolo [4,3–a][1,4]benzodiazepine)
- (12) Ethyl Loflazepate (ethyl 7–chloro–5–(o–fluorophenyl)–2,3–dihydro–2–oxo–1H–1,4–benzodiazepine–3–carboxylate)
- (13) Fludiazepam (7–chloro–5–(o–fluorophenyl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
- (14) [Repealed, SOR/98-173, s. 2]
- (15) Flurazepam (7–chloro–1–[2–(diethylamino) ethyl]–5–(o–fluorophenyl)–1,3–dihydro–2H–1,4–benzodiazepin–2–one)
- (16) Halazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2,2,2–trifluoroethyl)–2H–1,4–benzodiazepin–2–one)
- (17) Haloxazolam (10–bromo–11b–(o–fluorophenyl)–2,3,7,11b–tetrahydrooxazolo[3,2–d][1,4]benzodiazepin–6(5H)–one)
- (18) Ketazolam (11–chloro–8,12b–dihydro–2,8–dimethyl–12b–phenyl–4H–[1,3]–oxazino–[3,2–d][1,4] benzodiazepine–4,7(6H)–dione)
- (19) Loprazolam (6–(o–chlorophenyl)–2,4–dihydro–2–[(4–methyl–1–piperazinyl)methylene]–8–nitro–1H–imidazo[1,2–a][1,4]benzodiazepin–1–one)
- (20) Lorazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–2H–1,4–benzodiazepin–2–one)
- (21) Lormetazepam (7–chloro–5–(o–chlorophenyl)–1,3–dihydro–3–hydroxy–1–methyl–2H–1,4–benzodiazepin–2–one)
- (22) Medazepam (7–chloro–2,3–dihydro–1–methyl–5–phenyl–1H–1,4–benzodiazepine)
- (22.1) Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
- (23) Nimetazepam (1,3–dihydro–1–methyl–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (24) Nitrazepam (1,3–dihydro–7–nitro–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (25) Nordazepam (7–chloro–1,3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (26) Oxazepam (7–chloro–1,3–dihydro–3–hydroxy–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (27) Oxazolam (10–chloro–2,3,7,11b–tetrahydro–2–methyl–11b–phenyloxazolo[3,2–d] [1,4]benzodiazepin–6(5H)–one)
- (28) Pinazepam (7–chloro–1,3–dihydro–5–phenyl–1–(2–propynyl)–2H–1,4–benzodiazepin–2–one)
- (29) Prazepam (7–chloro–1–(cyclopropylmethyl)–1, 3–dihydro–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (29.1) Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)
- (30) Temazepam (7–chloro–1,3–dihydro–3–hydroxy–1–methyl–5–phenyl–2H–1,4–benzodiazepin–2–one)
- (31) Tetrazepam (7–chloro–5–(cyclohexen–1–yl)–1,3–dihydro–1–methyl–2H–1,4–benzodiazepin–2–one)
- (32) Triazolam (8–chloro–6–(o–chlorophenyl)–1–methyl–4H–s–triazolo[4,3–a][1,4]benzodiazepine)
but not including:
- (32.1) Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof
- (33) Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
- (34) Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts
- (35) Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts
19. Catha edulis Forsk., its preparations, derivatives, alkaloids and salts, including:
- (1) Cathine (d–threo–2–amino–1–hydroxy–1–phenylpropane)
20. Fencamfamin (d,l–N–ethyl–3–phenylbicyclo[2,2,1] heptan–2–amine) and any salt thereof
21. Fenproporex (d,l–3–[(α–methylphenethyl)amino]propionitrile) and any salt thereof
22. Mefenorex (d,l–N–(3–chloropropyl)–α–methylbenzeneethanamine) and any salt thereof
23. Anabolic steroids and their derivatives including:
- (1) Androisoxazole (17ß–hydroxy–17α–methylandrostano [3,2–c]isoxazole)
- (2) Androstanolone (17ß–hydroxy–5α–androstan–3–one)
- (3) Androstenediol (androst–5–ene–3ß,17ß–diol)
- (4) Bolandiol (estr–4–ene–3ß,17ß–diol)
- (5) Bolasterone (17ß–hydroxy–7a,17–dimethylandrost–4–en–3–one)
- (6) Bolazine (17ß–hydroxy–2a–methyl–5α–androstan–3–one azine)
- (7) Boldenone (17ß–hydroxyandrosta–1,4–dien–3–one)
- (8) Bolenol (19–nor–17a–pregn–5–en–17–ol)
- (9) Calusterone (17ß–hydroxy–7ß,17–dimethylandrost–4–en–3–one)
- (10) Clostebol (4–chloro–17ß–hydroxyandrost–4–en–3–one)
- (11) Drostanolone (17ß–hydroxy–2a–methyl–5α–androstan–3–one)
- (12) Enestebol (4, 17ß–dihydroxy–17–methylandrosta–1,4–dien–3–one)
- (13) Epitiostanol (2a, 3a–epithio–5α–androstan–17ß–ol)
- (14) Ethylestrenol (19–nor–17a–pregn–4–en–17–ol)
- (15) 4–Hydroxy–19–nor testosterone
- (16) Fluoxymesterone (9–fluoro–11ß,17ß–dihydroxy–17–methylandrost–4–en–3–one)
- (17) Formebolone (11a, 17ß–dihydroxy–17–methyl–3–oxoandrosta–1,4 di–en–2–carboxaldehyde)
- (18) Furazabol (17–methyl–5α–androstano[2,3–c] furazan–17ß–ol)
- (19) Mebolazine (17ß–hydroxy–2a,17–dimethyl–5α–androstan–3–one azine)
- (20) Mesabolone (17ß–[(1–methoxycyclohexyl)oxy]–5α–androst–1–en–3–one)
- (21) Mesterolone (17ß–hydroxy–1a–methyl–5α–androstan–3–one)
- (22) Metandienone (17ß–hydroxy–17–methylandrosta–1,4–dien–3–one)
- (23) Metenolone (17ß–hydroxy–1–methyl–5α–androst–1–en–3–one)
- (24) Methandriol (17α–methylandrost–5–ene–3ß,17ß–diol)
- (25) Methyltestosterone (17ß–hydroxy–17–methylandrost–4–en–3–one)
- (26) Metribolone (17ß–hydroxy–17–methylestra–4, 9,11–trien–3–one)
- (27) Mibolerone (17ß–hydroxy–7α,17–dimethylestr–4–en–3–one)
- (28) Nandrolone (17ß–hydroxyestr–4–en–3–one)
- (29) Norboletone (13–ethyl–17ß–hydroxy–18, 19–dinorpregn–4–en–3–one)
- (30) Norclostebol (4–chloro–17ß–hydroxyestr–4–en–3–one)
- (31) Norethandrolone (17α–ethyl–17ß–hydroxyestr–4–en–3–one)
- (32) Oxabolone (4,17ß–dihydroxyestr–4–en–3–one)
- (33) Oxandrolone (17ß–hydroxy–17–methyl–2–oxa–5α–androstan–3–one)
- (34) Oxymesterone (4,17ß–dihydroxy–17–methylandrost–4–en–3–one)
- (35) Oxymetholone (17ß–hydroxy–2–(hydroxymethylene)–17–methyl–5α–androstan–3–one)
- (36) Prasterone (3ß–hydroxyandrost–5–en–17–one)
- (37) Quinbolone (17ß–(1–cyclopenten–1–yloxy) androsta–1,4–dien–3–one)
- (38) Stanozolol (17ß–hydroxy–17–methyl–5α–androstano [3,2–c]pyrazole)
- (39) Stenbolone (17ß–hydroxy–2–methyl–5α–androst–1–en–3–one)
- (40) Testosterone (17ß–hydroxyandrost–4–en–3–one)
- (41) Tibolone ((7α,17α)-17–hydroxy–7–methyl–19–norpregn–5(10) en–20–yn–3–one)
- (42) Tiomesterone (1α,7α–bis(acetylthio)–17ß–hydroxy–17–methylandrost–4–en–3–one)
- (43) Trenbolone (17ß–hydroxyestra–4,9,11–trien–3–one)
24. Zeranol (3,4,5,6,7,8,9,10,11,12–decahydro–7,14,16–trihydroxy–3–methyl–1H–2–benzoxacyclotetradecin–1–one)
25. Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof
25.1 Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof
26. Pyrovalerone (4'-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
27. Salvia divinorum (S. divinorum), its preparations and derivatives, including:
- (1) Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)
1996, c. 19, Sch. IV; SOR/97-230, ss. 11 to 15; SOR/98-173, s. 2; SOR/99-371, s. 3; SOR/99-421, s. 2(E); SOR/2000-220, s. 2; SOR/2003-32, s. 6; SOR/2003-37; SOR/2015-209; 2017, c. 7, s. 49; SOR/2017-13, ss. 7 to 9, 10(E), 11, 12; SOR/2018-70, s. 4.
–
SCHEDULE V
(Sections 2, 5 to 7.1, 10, 55 and 60.1)
1996, c. 19, Sch. V; SOR/2002-361, s. 1; SOR/2003-32, s. 7; 2017, c. 7, s. 50.
–
SCHEDULE VI
- SCHEDULE VI
- (Sections 2, 6, 55 and 60)
- PART 1
- Class A Precursors[1]
2 N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts
3 Anthranilic acid (2-aminobenzoic acid) and its salts
4 Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
5 Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
6 Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts
7 Isosafrole (5-(1-propenyl)-1,3-benzodioxole)
8 Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts
9 3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone)
10 Norephedrine (Phenylpropanolamine) and its salts
11 1-Phenyl-2-propanone
12 Phenylacetic acid and its salts
13 Piperidine and its salts
14 Piperonal (1,3-benzodioxole-5-carboxaldehyde)
15 Potassium permanganate
16 Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
17 Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole
18 Gamma-butyrolactone (dihydro-2(3H)-furanone)
19 1,4-butanediol
20 Red Phosphorus
21 White Phosphorus
22 Hypophosphorous acid, its salts and derivatives
23 Hydriodic acid
24 Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers
25 Propionyl chloride
26 1-Phenethyl-4-piperidone and its salts
27 4-Piperidone and its salts
28 Norfentanyl (N-phenyl-N-piperidin-4-ylpropanamide) and its salts
29 1-Phenethylpiperidin-4-ylidenephenylamine and its salts
30 N-Phenyl-4-piperidinamine and its salts
31 N1,N1,N2-trimethylcyclohexane-1,2-diamine and its salts
- PART 2
- Class B Precursors[2]
1 Acetone
2 Ethyl ether
3 Hydrochloric acid
4 Methyl ethyl ketone
5 Sulphuric acid
6 Toluene
- PART 3
- Preparations and Mixtures
1 Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23, or in Part 2.
1996, c. 19, Sch. VI; SOR/2002-361, s. 2; 2005-364, ss. 1, 2, 3(F), 4; SOR/2016-13, 295; SOR/2017-277, s. 2.
–
SCHEDULE VII
[Repealed, 2018, c. 16, s. 205]
SCHEDULE VIII
[Repealed, 2018, c. 16, s. 205]
SCHEDULE IX
(Sections 2 and 60)
1. Manual, semi-automatic or fully automatic device that may be used to compact or mould powdered, granular or semi-solid material to produce coherent solid tablets
2. Manual, semi-automatic or fully automatic device that may be used to fill capsules with any powdered, granular, semi-solid or liquid material
2017, c. 7, s. 51.
–
Source
|